Page last updated: 2024-09-05

sb 203580 and nisoxetine

sb 203580 has been researched along with nisoxetine in 1 studies

Compound Research Comparison

Studies
(sb 203580)
Trials
(sb 203580)
Recent Studies (post-2010)
(sb 203580)
Studies
(nisoxetine)
Trials
(nisoxetine)
Recent Studies (post-2010) (nisoxetine)
3,48941,137316262

Protein Interaction Comparison

ProteinTaxonomysb 203580 (IC50)nisoxetine (IC50)
Cytochrome P450 1A1Homo sapiens (human)0.0079
Cytochrome P450 1A2Homo sapiens (human)0.0079
Prostaglandin G/H synthase 1Homo sapiens (human)2.4
Sodium-dependent noradrenaline transporter Homo sapiens (human)0.0131
Sodium-dependent dopamine transporterRattus norvegicus (Norway rat)0.0083
Sodium-dependent serotonin transporterHomo sapiens (human)0.8628
Sodium-dependent dopamine transporter Homo sapiens (human)1.65

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Campos-Torres, A; Haase, J; Malynn, S; Moynagh, P1

Other Studies

1 other study(ies) available for sb 203580 and nisoxetine

ArticleYear
The pro-inflammatory cytokine TNF-α regulates the activity and expression of the serotonin transporter (SERT) in astrocytes.
    Neurochemical research, 2013, Volume: 38, Issue:4

    Topics: Astrocytes; Cell Line, Tumor; Citalopram; Fluoxetine; Glioma; Humans; Imidazoles; p38 Mitogen-Activated Protein Kinases; Paroxetine; Pyridines; Serotonin; Serotonin Plasma Membrane Transport Proteins; Tumor Necrosis Factor-alpha

2013